Tag Archives: Myeloma

Sarclisa Combination Therapy Boosts Myeloma Remission Rates in Phase 3 Trial

(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab) combined with carfilzomib, lenalidomide, and dexamethasone (KRd) demonstrated a significant improvement in achieving minimal residual disease (MRD) negativity among newly … Read the full press release

Research shows the possibility to prevent incurable type of blood cancer from developing with early medical intervention

BIRMINGHAM, 14-Jul-2016 — /EuropaWire/ — Researchers from the University of Birmingham and hospitals across the West Midlands have revealed how a common symptomless condition can develop into the blood cancer myeloma. They discovered that changes in the bone marrow needed for … Read the full press release